{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:32:51Z","timestamp":1784194371343,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.ijantimicag.2006.05.032","type":"journal-article","created":{"date-parts":[[2006,8,31]],"date-time":"2006-08-31T12:49:18Z","timestamp":1157028558000},"page":"292-296","source":"Crossref","is-referenced-by-count":21,"title":["Viridans group streptococci in blood culture isolates in a Swedish university hospital: antibiotic susceptibility and identification of erythromycin resistance genes"],"prefix":"10.1016","volume":"28","author":[{"given":"Katarina","family":"Westling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Julander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shah","family":"Jalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Erik","family":"Nord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Wretlind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2006.05.032_bib1","first-page":"1768","article-title":"Invasive infections by Streptococcus viridans (oral streptococci) excluding pneumococci","volume":"26","author":"Bouvet","year":"1997","journal-title":"Presse Med"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib2","unstructured":"National Registry of Infective Endocarditis. Swedish Society of Infectious Diseases; 2002."},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib3","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1001\/jama.274.21.1706","article-title":"Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association","volume":"274","author":"Wilson","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-9343(94)90009-4","article-title":"Bacteremia due to viridans streptococci in neutropenic patients: a review","volume":"97","author":"Bochud","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib5","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/340402","article-title":"Infections caused by viridans streptococci in patients with neutropenia","volume":"34","author":"Tunkel","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/clinids\/23.4.795","article-title":"Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis","volume":"23","author":"Cruciani","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s005200050219","article-title":"Activity of quinolones against viridans group streptococci isolated from blood cultures of patients with haematological malignancy","volume":"7","author":"Kerr","year":"1999","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(94)90143-0","article-title":"New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service","volume":"96","author":"Durack","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib9","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1099\/ijs.0.02639-0","article-title":"Phylogenetic relationships and genotyping of the genus Streptococcus by sequence determination of the RNase P RNA gene, rnpB","volume":"53","author":"Tapp","year":"2003","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib10","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/clinids\/20.5.1169","article-title":"Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer","volume":"20","author":"Carratala","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/AAC.49.2.827-829.2005","article-title":"Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes","volume":"49","author":"Ardanuy","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib12","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/AAC.46.5.1553-1556.2002","article-title":"Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000","volume":"46","author":"Gershon","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib13","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/jac\/dkh159","article-title":"Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistance","volume":"53","author":"Lyytikainen","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib14","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1056\/NEJM199906103402319","article-title":"Prosthetic-valve endocarditis caused by penicillin-resistant Streptococcus mitis","volume":"340","author":"Levitz","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/321910","article-title":"Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy","volume":"33","author":"Levy","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib16","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1128\/AAC.48.11.4463-4465.2004","article-title":"Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002","volume":"48","author":"Prabhu","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/00365540110077434","article-title":"Streptococcus viridans septicaemia: a comparison study in patients admitted to the departments of infectious diseases and haematology in a university hospital","volume":"34","author":"Westling","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1469-0691.2004.00975.x","article-title":"Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease","volume":"10","author":"Westling","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/AAC.24.5.702","article-title":"Multiply resistant viridans streptococci: susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patterns","volume":"24","author":"Farber","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1198-743x.2001.00398.x","article-title":"Viridans group streptococci: a reservoir of resistant bacteria in oral cavities","volume":"8","author":"Bryskier","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/00365540410019435","article-title":"Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents","volume":"36","author":"Smith","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jac\/48.4.592","article-title":"High prevalence of erythromycin-resistant and clindamycin-susceptible (M phenotype) viridans group streptococci from pharyngeal samples: a reservoir of mef genes in commensal bacteria","volume":"48","author":"Aracil","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib23","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0140-6736(00)04972-2","article-title":"Variation in antibiotic use in the European Union","volume":"357","author":"Cars","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0924-8579(00)00216-8","article-title":"Antibacterial prophylaxis","volume":"16","author":"Cruciani","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jac\/44.6.775","article-title":"Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci","volume":"44","author":"Entenza","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/345744","article-title":"Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program","volume":"36","author":"Birmingham","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib27","first-page":"411","article-title":"A case of Streptococcus mitis endocarditis successfully treated by linezolid","volume":"11","author":"Ng","year":"2005","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib28","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1086\/375877","article-title":"Failure of linezolid treatment for enterococcal endocarditis","volume":"37","author":"Zimmer","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1469-0691.2004.01051.x","article-title":"Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres","volume":"11","author":"Gales","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/jac\/dkh401","article-title":"Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods","volume":"54","author":"Mushtaq","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0732-8893(01)00269-3","article-title":"In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases","volume":"40","author":"Biedenbach","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib32","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/AAC.46.8.2595-2601.2002","article-title":"In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens","volume":"46","author":"Petersen","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1039\/b416648p","article-title":"Natural products to drugs: daptomycin and related lipopeptide antibiotics","volume":"22","author":"Baltz","year":"2005","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib34","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.inf.0000181741.59226.a0","article-title":"Antimicrobial update: daptomycin","volume":"24","author":"Oberholzer","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2006.05.032_bib35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1179\/joc.2005.17.5.477","article-title":"Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003","volume":"17","author":"Sader","year":"2005","journal-title":"J Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906002652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906002652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,13]],"date-time":"2019-01-13T18:20:45Z","timestamp":1547403645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857906002652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0924857906002652"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2006.05.032","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}